TAKEDA PHARMACEUTICAL CO LTD (TAK) has 43 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 19 sales totalling $13.1M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 14, 2026 | Duprey Lauren Rusckowski Chief Transformation Officer | −$640,279 | 34,535 | −15% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 2, 2026 | Plump Andrew Stewart President, R&D | −$2,148,372 | 116,191 | −44% | Yes | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | Plump Andrew Stewart President, R&D | −$363,347 | 19,651 | −7% | Yes | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 18, 2026 | Greenway Nicola Deidre Petal Chief Human Resources Officer | −$235,118 | 12,980 | −24% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Pacheco Rhonda Janice President, U.S. Business Unit | −$289,007 | 16,901 | −8% | No | |
|
|
||||||
Showing the 5 most recent of 43 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free